Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial.

Broekhuijsen K, van Baaren GJ, van Pampus MG, Ganzevoort W, Sikkema JM, Woiski MD, Oudijk MA, Bloemenkamp KW, Scheepers HC, Bremer HA, Rijnders RJ, van Loon AJ, Perquin DA, Sporken JM, Papatsonis DN, van Huizen ME, Vredevoogd CB, Brons JT, Kaplan M, van Kaam AH, Groen H, Porath MM, van den Berg PP, Mol BW, Franssen MT, Langenveld J; HYPITAT-II study group.

Lancet. 2015 Jun 20;385(9986):2492-501. doi: 10.1016/S0140-6736(14)61998-X. Epub 2015 Mar 25. Erratum in: Lancet. 2016 Feb 27;387(10021):848.

PMID:
25817374
2.

Maternal allopurinol administration during suspected fetal hypoxia: a novel neuroprotective intervention? A multicentre randomised placebo controlled trial.

Kaandorp JJ, Benders MJ, Schuit E, Rademaker CM, Oudijk MA, Porath MM, Oetomo SB, Wouters MG, van Elburg RM, Franssen MT, Bos AF, de Haan TR, Boon J, de Boer IP, Rijnders RJ, Jacobs CJ, Scheepers LH, Gavilanes DA, Bloemenkamp KW, Rijken M, van Meir CA, von Lindern JS, Huisjes AJ, Bakker SC, Mol BW, Visser GH, Van Bel F, Derks JB.

Arch Dis Child Fetal Neonatal Ed. 2015 May;100(3):F216-23. doi: 10.1136/archdischild-2014-306769. Epub 2014 Dec 15.

PMID:
25512466
3.

Prediction of neonatal outcome in women with gestational hypertension or mild preeclampsia after 36 weeks of gestation.

van der Tuuk K, Holswilder-Olde Scholtenhuis MA, Koopmans CM, van den Akker ES, Pernet PJ, Ribbert LS, van Meir CA, Boers K, Drogtrop AP, van Loon AJ, Hanssen MJ, Sporken JM, Mol BW, van den Berg PP, Groen H, van Pampus MG; HYPITAT study group.

J Matern Fetal Neonatal Med. 2015 May;28(7):783-9. doi: 10.3109/14767058.2014.935323. Epub 2014 Jul 17.

PMID:
24949930
4.

Economic analysis comparing induction of labour and expectant management for intrauterine growth restriction at term (DIGITAT trial).

Vijgen SM, Boers KE, Opmeer BC, Bijlenga D, Bekedam DJ, Bloemenkamp KW, de Boer K, Bremer HA, le Cessie S, Delemarre FM, Duvekot JJ, Hasaart TH, Kwee A, van Lith JM, van Meir CA, van Pampus MG, van der Post JA, Rijken M, Roumen FJ, van der Salm PC, Spaanderman ME, Willekes C, Wijnen EJ, Mol BW, Scherjon SA.

Eur J Obstet Gynecol Reprod Biol. 2013 Oct;170(2):358-63. doi: 10.1016/j.ejogrb.2013.07.017. Epub 2013 Aug 1.

PMID:
23910171
5.

Health-related quality of life after induction of labor versus expectant monitoring in gestational hypertension or preeclampsia at term.

Bijlenga D, Koopmans CM, Birnie E, Mol BW, van der Post JA, Bloemenkamp KW, Scheepers HC, Willekes C, Kwee A, Heres MH, Van Beek E, Van Meir CA, Van Huizen ME, Van Pampus MG, Bonsel GJ.

Hypertens Pregnancy. 2011;30(3):260-74. doi: 10.3109/10641955.2010.486458.

PMID:
21740249
6.

Induction versus expectant monitoring for intrauterine growth restriction at term: randomised equivalence trial (DIGITAT).

Boers KE, Vijgen SM, Bijlenga D, van der Post JA, Bekedam DJ, Kwee A, van der Salm PC, van Pampus MG, Spaanderman ME, de Boer K, Duvekot JJ, Bremer HA, Hasaart TH, Delemarre FM, Bloemenkamp KW, van Meir CA, Willekes C, Wijnen EJ, Rijken M, le Cessie S, Roumen FJ, Thornton JG, van Lith JM, Mol BW, Scherjon SA; DIGITAT study group.

BMJ. 2010 Dec 21;341:c7087. doi: 10.1136/bmj.c7087.

7.

Antenatal allopurinol for reduction of birth asphyxia induced brain damage (ALLO-Trial); a randomized double blind placebo controlled multicenter study.

Kaandorp JJ, Benders MJ, Rademaker CM, Torrance HL, Oudijk MA, de Haan TR, Bloemenkamp KW, Rijken M, van Pampus MG, Bos AF, Porath MM, Oetomo SB, Willekes C, Gavilanes AW, Wouters MG, van Elburg RM, Huisjes AJ, Bakker SC, van Meir CA, von Lindern J, Boon J, de Boer IP, Rijnders RJ, Jacobs CJ, Uiterwaal CS, Mol BW, Visser GH, van Bel F, Derks JB.

BMC Pregnancy Childbirth. 2010 Feb 18;10:8. doi: 10.1186/1471-2393-10-8.

8.

Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial.

Koopmans CM, Bijlenga D, Groen H, Vijgen SM, Aarnoudse JG, Bekedam DJ, van den Berg PP, de Boer K, Burggraaff JM, Bloemenkamp KW, Drogtrop AP, Franx A, de Groot CJ, Huisjes AJ, Kwee A, van Loon AJ, Lub A, Papatsonis DN, van der Post JA, Roumen FJ, Scheepers HC, Willekes C, Mol BW, van Pampus MG; HYPITAT study group.

Lancet. 2009 Sep 19;374(9694):979-88. doi: 10.1016/S0140-6736(09)60736-4. Epub 2009 Aug 3.

PMID:
19656558
9.

Disproportionate Intrauterine Growth Intervention Trial At Term: DIGITAT.

Boers KE, Bijlenga D, Mol BW, LeCessie S, Birnie E, van Pampus MG, Stigter RH, Bloemenkamp KW, van Meir CA, van der Post JA, Bekedam DJ, Ribbert LS, Drogtrop AP, van der Salm PC, Huisjes AJ, Willekes C, Roumen FJ, Scheepers HC, de Boer K, Duvekot JJ, Thornton JG, Scherjon SA.

BMC Pregnancy Childbirth. 2007 Jul 10;7:12.

10.

Carrier diagnostics and prevention of hemoglobinopathies in early pregnancy in The Netherlands: a pilot study.

Giordano PC, Plancke A, Van Meir CA, Janssen CA, Kok PJ, Van Rooijen-Nijdam IH, Tanis BC, van Huisseling JC, Versteegh FG.

Prenat Diagn. 2006 Aug;26(8):719-24.

PMID:
16752436
11.

Pre-term birth and severe pre-eclampsia are not associated with altered expression of HLA on human trophoblasts.

Datema G, van Meir CA, Kanhai HH, van den Elsen PJ.

Am J Reprod Immunol. 2003 Apr;49(4):193-201.

PMID:
12852493
12.

[Delayed birth of the second child in multiple gestation].

Weemhoff M, van Meir CA, Walther FJ, Twaalfhoven FC, van Roosmalen J.

Ned Tijdschr Geneeskd. 2001 Jul 21;145(29):1377-80. Review. Dutch.

PMID:
11494684
13.

Chorionic prostaglandin catabolism is decreased in the lower uterine segment with term labour.

Van Meir CA, Ramirez MM, Matthews SG, Calder AA, Keirse MJ, Challis JR.

Placenta. 1997 Mar-Apr;18(2-3):109-14.

PMID:
9089770
14.

15-hydroxyprostaglandin dehydrogenase: implications in preterm labor with and without ascending infection.

van Meir CA, Matthews SG, Keirse MJ, Ramirez MM, Bocking A, Challis JR.

J Clin Endocrinol Metab. 1997 Mar;82(3):969-76.

PMID:
9062515
15.

Immunoreactive 15-hydroxyprostaglandin dehydrogenase (PGDH) is reduced in fetal membranes from patients at preterm delivery in the presence of infection.

Van Meir CA, Sangha RK, Walton JC, Matthews SG, Keirse MJ, Challis JR.

Placenta. 1996 Jul-Aug;17(5-6):291-7.

PMID:
8829211

Supplemental Content

Loading ...
Support Center